Skip to main content

Table 1 Summary of 4 cases

From: Nontuberculous mycobacterial infection after lung transplantation: a report of four cases

Case No. Age Sex Primary disease Donar Procedure Period to onseta (Month) Organism Infection lung Symptom Diagnosis Drug Period to negative conversion (month) Treatment period (month) Reinfection outcome
1 10 M PAH Living Bilateral Late (76) M.gordonae Transplanted None BAL None 5 None Alive
2 35 F BE Living Bilateral Late (82) MABSC Transplanted Fever
BAL TAZ/PIPC+AZM 1 22 None Alive
3 41 F LAM Cadaveric Single Late (58) MABSC Transplanted Sputum Sptum AZM + IPM + AMK 4 12 None Alive
4 39 M NSIP Cadaveric Single Early (12) M.intracellurare Native Fever Sptum REC 3 21 None Dead
  1. AZM azithromycin, BAL broncho-alveolar lavage, BE bronchiectasis, CyA Cycrosporin, LAM lymphangioleiomyomatosis, M. Mycobacterium, MMF mycophenolate mofetil, NSIP nonspecific interstitial puemonia, PAH pulmonary arterial hypertension, PSL prednisolone, REC Rifampicin, ethambutol, and clarithromycin
  2. aEarly onset considered to occur within 180 days, late onset from 180 days until 3 years, and very late onset after 3 years